blood cancer

A COMPREHENSIVE SERIES OF ARTICLES ON THIS TOPIC

Pfizer Inc. Research And Development Center Ahead Of Earnings Figures

Pfizer to acquire blood cancer drugmaker Trillium for €1.93bn

Pfizer’s oncology portfolio now includes 24 approved drugs

Mon, 23 Aug, 2021

NUIG researchers leading trial on potentially fatal multiple myeloma

Irish patients with blood cancer are the first worldwide to take part in a new drug trial to develop more effective treatment for multiple myeloma, a potentially fatal condition.

Tue, 28 Feb, 2017

Irish person with blood cancer first in world to take part in new drug trial

An Irish person has become the first in the world to take part in a new drug trial for patients with the blood cancer 'multiple myeloma'.

Tue, 27 Sep, 2016

blood cancer

Pfizer to acquire blood cancer drugmaker Trillium for €1.93bn

NUIG researchers leading trial on potentially fatal multiple myeloma

Irish person with blood cancer first in world to take part in new drug trial

Latest

Mick Clifford

blood cancer

Pfizer to acquire blood cancer drugmaker Trillium for €1.93bn

NUIG researchers leading trial on potentially fatal multiple myeloma

Irish person with blood cancer first in world to take part in new drug trial

Latest

Mick Clifford

Most Read